The board of ABRASTA takes part of periodical meetings with representatives of the State and local health departments (and with the National Health Council CNS – EXCLUDE) to discuss improvements in the treatment of thalassemia, especially as regards usage of more evolved drugs and other essential care in the treatment standard offered obligatorily by the Single Health System (SUS).
Meetings of CNS – National Health Council
Since 2006, the board of ABRASTA has a seat at CNS, comprised of representatives of organizations representing users of the SUS, government members and health professionals, actively taking part in the preparation and resolution of the most relevant public health policies for the population.
ABRASTA wants to represent the people with thalassemia and their relatives in the hearings called up by the Health Department, such as that of 2009 on dejudicialization – so that the laws which assure health to the population were complied without interference of the judiciary branch.
Latin-American network of associations for support to people bearing hematologic diseases which gathers efforts to achieve advancements in the area and has ABRASTA among its founders.
Board member of the Thalassemia International Federation (TIF)
ABRASTA is a TIF member, international entity which aggregates professionals from all continents for researches on the disease.
Seal We Invest in Life
A form that ABRASTA found to highlight some companies, more specifically those partners which support and sponsor projects of the association or that contribute somehow towards disseminating information on thalassemia. The seal is annually delivered, in a ceremony at FIESP, to the prominent companies.